173 related articles for article (PubMed ID: 29273105)
21. Alopecia areata update.
Alkhalifah A
Dermatol Clin; 2013 Jan; 31(1):93-108. PubMed ID: 23159179
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of alopecia areata: modern principles and perspectives].
Brajac I; Kastelan M; Perisa D; Simonić E; Stojnić-Sosa L; Massari LP
Lijec Vjesn; 2010; 132(11-12):365-9. PubMed ID: 21294327
[TBL] [Abstract][Full Text] [Related]
23. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
24. Alopecia Areata Progression Index, a Scoring System for Evaluating Overall Hair Loss Activity in Alopecia Areata Patients with Pigmented Hair: A Development and Reliability Assessment.
Jang YH; Moon SY; Lee WJ; Lee SJ; Lee WK; Park BC; Kim H; Kim DW
Dermatology; 2016; 232(2):143-9. PubMed ID: 26757319
[TBL] [Abstract][Full Text] [Related]
25. Quality of life in patients with alopecia areata: a hospital-based cross-sectional study.
Janković S; Perić J; Maksimović N; Ćirković A; Marinković J; Janković J; Reljić V; Medenica L
J Eur Acad Dermatol Venereol; 2016 May; 30(5):840-6. PubMed ID: 26660721
[TBL] [Abstract][Full Text] [Related]
26. Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort.
Clemmesen MER; Gren ST; Frøstrup AG; Thomsen SF; Egeberg A; Thein D
J Eur Acad Dermatol Venereol; 2024 Jun; ():. PubMed ID: 38940661
[TBL] [Abstract][Full Text] [Related]
27. The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata.
Gelhorn HL; Cutts K; Edson-Heredia E; Wright P; Delozier A; Shapiro J; Senna M; Tosti A
Dermatol Ther (Heidelb); 2022 Apr; 12(4):989-997. PubMed ID: 35352323
[TBL] [Abstract][Full Text] [Related]
28. What is the burden of living with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) in 2012? A health-related quality-of-life assessment in Finnish patients.
Kluger N; Jokinen M; Krohn K; Ranki A
Clin Endocrinol (Oxf); 2013 Jul; 79(1):134-41. PubMed ID: 23113742
[TBL] [Abstract][Full Text] [Related]
29. An update on alopecia areata.
Kos L; Conlon J
Curr Opin Pediatr; 2009 Aug; 21(4):475-80. PubMed ID: 19502982
[TBL] [Abstract][Full Text] [Related]
30. Development of a disease-specific instrument to measure quality of life in patients with alopecia areata.
Endo Y; Miyachi Y; Arakawa A
Eur J Dermatol; 2012; 22(4):531-6. PubMed ID: 22743283
[TBL] [Abstract][Full Text] [Related]
31. Recurrence of alopecia areata in a patient receiving etanercept injections.
Posten W; Swan J
Arch Dermatol; 2005 Jun; 141(6):759-60. PubMed ID: 15967923
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-1 receptor antagonist allele 2 and familial alopecia areata.
Barahmani N; de Andrade M; Slusser J; Zhang Q; Duvic M
J Invest Dermatol; 2002 Feb; 118(2):335-7. PubMed ID: 11841553
[TBL] [Abstract][Full Text] [Related]
33. Examining the relationship between alopecia areata, androgenetic alopecia, and emotional intelligence.
Monselise A; Bar-On R; Chan L; Leibushor N; McElwee K; Shapiro J
J Cutan Med Surg; 2013; 17(1):46-51. PubMed ID: 23364150
[TBL] [Abstract][Full Text] [Related]
34. Nail Involvement in Alopecia Areata: A Questionnaire-based Survey on Clinical Signs, Impact on Quality of Life and Review of the Literature.
Roest YBM; van Middendorp HT; Evers AWM; van de Kerkhof PCM; Pasch MC
Acta Derm Venereol; 2018 Feb; 98(2):212-217. PubMed ID: 28967977
[TBL] [Abstract][Full Text] [Related]
35. Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review.
Toussi A; Barton VR; Le ST; Agbai ON; Kiuru M
J Am Acad Dermatol; 2021 Jul; 85(1):162-175. PubMed ID: 32561373
[TBL] [Abstract][Full Text] [Related]
36. Associations between skin diseases and quality of life: a comparison of psoriasis, vitiligo, and alopecia areata.
Ghajarzadeh M; Ghiasi M; Kheirkhah S
Acta Med Iran; 2012; 50(7):511-5. PubMed ID: 22930385
[TBL] [Abstract][Full Text] [Related]
37. Quality of life in alopecia areata: a disease-specific questionnaire.
Fabbrocini G; Panariello L; De Vita V; Vincenzi C; Lauro C; Nappo D; Ayala F; Tosti A
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e276-81. PubMed ID: 22759244
[TBL] [Abstract][Full Text] [Related]
38. Alopecia areata: autoimmune basis of hair loss.
Alexis AF; Dudda-Subramanya R; Sinha AA
Eur J Dermatol; 2004; 14(6):364-70. PubMed ID: 15564197
[TBL] [Abstract][Full Text] [Related]
39. Introduction to innovations in the immunology and clinical science of alopecia areata.
Kalabokes VD; Bergfeld WF; Christiano AM
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S1-4. PubMed ID: 24326539
[TBL] [Abstract][Full Text] [Related]
40. Management of autoimmune associated alopecia areata.
McKillop J
Nurs Stand; 2010 May 12-18; 24(36):42-6. PubMed ID: 20527485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
